Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PHG
Strong BuyAPPROVEKoninklijke Philips N.V. · Healthcare · Netherlands · $26.1B · Avg Vol: $30M/d
Koninklijke Philips clears the calibrated bar on the stricter path, with all three legs above 60 (Q61 V62 M62) and therefore no requirement for a corroborating filing. Nothing adverse is on file: no negative earnings revision and no insider selling. The respiratory recall litigation that dominated the story has largely been settled, and medical imaging demand is supported by hospital capex recovery.
COMPANY DESCRIPTION
Koninklijke Philips N.V. is a global leader in health technology, specializing in diagnostic imaging, image-guided therapy, patient monitoring, and personal health products. The company has successfully transitioned from a diversified electronics conglomerate into a pure-play medical technology giant with a presence in over 100 countries. Its competitive moat is sustained by a massive patent portfolio, deep clinical partnerships, and integrated digital health platforms that connect hospital and home care.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 20.7B | 21.1B | 20.9B | 20.7B | 0.0% | 20.6B | 20.8B | 21.7B | 2.4% |
| EPS | -1.95 | -0.57 | -0.87 | 1.09 | — | 1.33 | 1.03 | 1.12 | 1.3% |
| Shares | 952.3M | 937.4M | 925.0M | 951.3M | -0.1% | 977.4M | — | — | — |
| Debt | 8.5B | 8.5B | 8.7B | 9.1B | 2.1% | 8.7B | — | — | — |
| Equity | 15.4B | 13.9B | 13.9B | 12.7B | -6.1% | — | — | — | — |
| Op CF | -200.5M | 2.5B | 1.8B | 1.4B | -25.9% | 2.7B | — | — | — |
| Inv CF | -1.7B | -737.0M | -664.0M | -854.0M | — | — | — | — | — |
| Fin CF | 579.4M | -982.6M | -574.7M | 124.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PHG are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PHG | Koninklijke Philips N.V.(you) | $26.1B | 84 | Strong Buy |
| QIA.DE | Qiagen N.V. | $8.8B | 80 | Buy |
| ARGX.BR | argenx SE | $64.5B | 75 | Buy |
| RDC.DE | Redcare Pharmacy NV | $1.4B | 54 | Hold |
| PHAR | Pharming Group N.V. | $828M | 55 | Hold |
| QURE | uniQure N.V. | $3.4B | 18 | Strong Sell |
| NAMS | NewAmsterdam Pharma Company N.V. | $3.0B | 9 | Strong Sell |
| PRQR | ProQR Therapeutics N.V. | $323M | 30 | Sell |
| ONWD.BR | Onward Medical N.V. | $199M | 4 | Strong Sell |
Peer medians: ROE 3.6% · P/E 39.9x · Gross margin 80.8%